William B. Abrams

1.2k total citations
51 papers, 926 citations indexed

About

William B. Abrams is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, William B. Abrams has authored 51 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pharmacology and 7 papers in Molecular Biology. Recurrent topics in William B. Abrams's work include Pharmaceutical studies and practices (5 papers), Pharmacology and Obesity Treatment (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). William B. Abrams is often cited by papers focused on Pharmaceutical studies and practices (5 papers), Pharmacology and Obesity Treatment (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). William B. Abrams collaborates with scholars based in United States, Switzerland and Japan. William B. Abrams's co-authors include Harvey M. Solomon, Peter H. Vlasses, Héctor W. Gómez, Mario L. Rocci, R. Davies, Parviz Mojaverian, Daniel W. Lewis, Steven D. Reich, Dale P. Conner and D. B. Brunner and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.

In The Last Decade

William B. Abrams

49 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William B. Abrams United States	18	265	263	131	102	96	51	926
Roger K. Ferguson United States	22	282 1.1×	461 1.8×	83 0.6×	148 1.5×	128 1.3×	71	1.2k
Marianne Frisk‐Holmberg Sweden	21	215 0.8×	300 1.1×	78 0.6×	89 0.9×	243 2.5×	54	1.3k
John D. Irvin United States	14	271 1.0×	384 1.5×	53 0.4×	147 1.4×	72 0.8×	30	955
Pitambar Somani United States	23	365 1.4×	609 2.3×	102 0.8×	53 0.5×	182 1.9×	83	1.3k
Ronald Okun United States	16	143 0.5×	143 0.5×	52 0.4×	93 0.9×	131 1.4×	49	802
R. Zacest Australia	12	161 0.6×	224 0.9×	46 0.4×	80 0.8×	114 1.2×	24	749
Robert F. Maronde United States	16	103 0.4×	241 0.9×	66 0.5×	87 0.9×	60 0.6×	54	873
Emil R. Smith United States	16	211 0.8×	107 0.4×	129 1.0×	66 0.6×	133 1.4×	45	840
Bengt‐Arne Persson Sweden	21	216 0.8×	120 0.5×	88 0.7×	90 0.9×	182 1.9×	37	1.4k
Karl H. Beyer United States	16	408 1.5×	92 0.3×	83 0.6×	77 0.8×	124 1.3×	65	1.2k

Countries citing papers authored by William B. Abrams

Since Specialization

Citations

This map shows the geographic impact of William B. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William B. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William B. Abrams more than expected).

Fields of papers citing papers by William B. Abrams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William B. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William B. Abrams. The network helps show where William B. Abrams may publish in the future.

Co-authorship network of co-authors of William B. Abrams

This figure shows the co-authorship network connecting the top 25 collaborators of William B. Abrams. A scholar is included among the top collaborators of William B. Abrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William B. Abrams. William B. Abrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abrams, William B., et al.. (2008). Relationship of Selected Pre-NBA Career Variables to NBA Players' Career Longevity. The Sport Journal. 11(2). 5 indexed citations

Ramirez, Julio J., et al.. (1999). Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats. Neuroreport. 10(6). 1201–1204. 36 indexed citations

Abrams, William B. & Mark H. Beers. (1998). Clinical pharmacology in an aging population. Clinical Pharmacology & Therapeutics. 63(3). 281–284. 17 indexed citations

Rotmensch, Heschi H., et al.. (1993). Comparisons of Beta‐Adrenergic Blocking Properties of S‐ and R‐Timolol in Humans. The Journal of Clinical Pharmacology. 33(6). 544–548. 1 indexed citations

Cummings, Doyle M., Peter C. Amadio, Donald J. Balaban, et al.. (1989). The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population. The Journal of Clinical Pharmacology. 29(1). 25–32. 7 indexed citations

Abrams, William B.. (1988). Pathophysiology of hypertension in older patients. The American Journal of Medicine. 85(3). 7–13. 25 indexed citations

Abrams, William B.. (1985). Introduction. Drug Information Journal. 19(4). 395–396. 1 indexed citations

Abrams, William B.. (1985). Drugs and the elderly.. PubMed. 19(6). 1–6. 1 indexed citations

Vlasses, Peter H., R Ferguson, John D. Irvin, et al.. (1982). Synergistic antihypertensive effect of MK-421 and hydrochlorothiazide. The American Journal of Cardiology. 49(4). 923–923. 3 indexed citations

10.

Biollaz, Jérôme, Michel Burnier, G. A. Turini, et al.. (1981). Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I. Clinical Pharmacology & Therapeutics. 29(5). 665–670. 127 indexed citations

11.

Vlasses, Peter H., Anne Holbrook, John J. Schrogie, et al.. (1980). Effect of orally administered probenecid on the pharmacokinetics of cefoxitin. Antimicrobial Agents and Chemotherapy. 17(5). 847–855. 22 indexed citations

12.

Solomon, Harvey M. & William B. Abrams. (1972). Interactions between digitoxin and other drugs in man. American Heart Journal. 83(2). 277–280. 37 indexed citations

13.

Solomon, Harvey M., et al.. (1971). INTERACTIONS BETWEEN DIGITOXIN AND OTHER DRUGS IN VITRO AND IN VIVO. Annals of the New York Academy of Sciences. 179(1). 362–369. 53 indexed citations

14.

Malmfors, Torbjörn & William B. Abrams. (1970). THE EFFECTS OF DEBRISOQUIN AND BRETYLIUM ON ADRENERGIC NERVES AS REVEALED BY FLUORESCENCE HISTOCHEMISTRY. Journal of Pharmacology and Experimental Therapeutics. 174(1). 99–110. 3 indexed citations

15.

Gaut, Zane N., et al.. (1969). A new approach to the use of histamine skin tests in the study of antihistamine drugs. Clinical Pharmacology & Therapeutics. 10(2). 250–257. 10 indexed citations

16.

Abrams, William B.. (1969). The Mechanisms of Action of Antihypertensive Drugs. Diseases of the Chest. 55(2). 148–159. 5 indexed citations

17.

Abrams, William B., et al.. (1965). The Clinical Pharmacology of Postganglionic Sympathetic Blocking Agents* *From the Special Treatment Units of the Newark City and Beth Israel Hospitals and the Departments of Pharmacology and Clinical Pharmacology of Hoffmann-La Roche Inc.. Diseases of the Chest. 48(2). 178–186. 5 indexed citations

18.

Abrams, William B. & Maurice J. Small. (1960). Current Concepts of Tuberculous Pleurisy with Effusion as Derived from Pleural Biopsy Studies. Diseases of the Chest. 38(1). 60–65. 8 indexed citations

19.

Abrams, William B.. (1957). Arteriosclerosis of the Aorta. A M A Archives of Internal Medicine. 100(2). 283–283. 2 indexed citations

20.

Abrams, William B., et al.. (1953). A Ballistocardiographic Study of Healthy Young Adult Males. Circulation. 8(5). 738–743. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact